These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 10387403)

  • 1. Threats to applicability of randomised trials: exclusions and selective participation.
    Britton A; McKee M; Black N; McPherson K; Sanderson C; Bain C
    J Health Serv Res Policy; 1999 Apr; 4(2):112-21. PubMed ID: 10387403
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies.
    MacLehose RR; Reeves BC; Harvey IM; Sheldon TA; Russell IT; Black AM
    Health Technol Assess; 2000; 4(34):1-154. PubMed ID: 11134917
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation.
    Picot J; Jones J; Colquitt JL; Gospodarevskaya E; Loveman E; Baxter L; Clegg AJ
    Health Technol Assess; 2009 Sep; 13(41):1-190, 215-357, iii-iv. PubMed ID: 19726018
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A review of reporting of participant recruitment and retention in RCTs in six major journals.
    Toerien M; Brookes ST; Metcalfe C; de Salis I; Tomlin Z; Peters TJ; Sterne J; Donovan JL
    Trials; 2009 Jul; 10():52. PubMed ID: 19591685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of randomized controlled trials discontinued or revised for poor recruitment and completed trials with the same research question: a matched qualitative study.
    Briel M; Speich B; von Elm E; Gloy V
    Trials; 2019 Dec; 20(1):800. PubMed ID: 31888725
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ineligibility and refusal to participate in randomised trials of treatments for drug dependence.
    Melberg HO; Humphreys K
    Drug Alcohol Rev; 2010 Mar; 29(2):193-201. PubMed ID: 20447229
    [TBL] [Abstract][Full Text] [Related]  

  • 7. "Nothing to lose and the possibility of gaining": a qualitative study on the feasibility and acceptability of registry-based randomised controlled trials among cancer patients and clinicians.
    Prang KH; Karanatsios B; Zhang A; Verbunt E; Wong HL; Wong V; Gately L; Tran B; Gibbs P; Kelaher M
    Trials; 2023 Feb; 24(1):92. PubMed ID: 36747274
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A systematic review of discontinued trials suggested that most reasons for recruitment failure were preventable.
    Briel M; Olu KK; von Elm E; Kasenda B; Alturki R; Agarwal A; Bhatnagar N; Schandelmaier S
    J Clin Epidemiol; 2016 Dec; 80():8-15. PubMed ID: 27498376
    [TBL] [Abstract][Full Text] [Related]  

  • 9. "Why don't they just tell me straight, why allocate it?" The struggle to make sense of participating in a randomised controlled trial.
    Featherstone K; Donovan JL
    Soc Sci Med; 2002 Sep; 55(5):709-19. PubMed ID: 12190265
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Reasons for participation and non-participation in a randomized controlled trial: postal questionnaire surveys of women eligible for TOMBOLA (Trial Of Management of Borderline and Other Low-Grade Abnormal smears).
    Sharp L; Cotton SC; Alexander L; Williams E; Gray NM; Reid JM;
    Clin Trials; 2006; 3(5):431-42. PubMed ID: 17060217
    [TBL] [Abstract][Full Text] [Related]  

  • 11. How to generalize efficacy results of randomized trials: recommendations based on a systematic review of possible approaches.
    Post PN; de Beer H; Guyatt GH
    J Eval Clin Pract; 2013 Aug; 19(4):638-43. PubMed ID: 22862884
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Disparities in the participation and adherence of older adults in lifestyle-based multidomain dementia prevention and the motivational role of perceived disease risk and intervention benefits: an observational ancillary study to a randomised controlled trial.
    Coley N; Coniasse-Brioude D; Igier V; Fournier T; Poulain JP; Andrieu S;
    Alzheimers Res Ther; 2021 Sep; 13(1):157. PubMed ID: 34560903
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Doubly blind: a systematic review of gender in randomised controlled trials.
    Phillips SP; Hamberg K
    Glob Health Action; 2016; 9():29597. PubMed ID: 27087576
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The external validity of published randomized controlled trials in primary care.
    Jones R; Jones RO; McCowan C; Montgomery AA; Fahey T
    BMC Fam Pract; 2009 Jan; 10():5. PubMed ID: 19152681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reporting the recruitment process in clinical trials: who are these patients and how did they get there?
    Gross CP; Mallory R; Heiat A; Krumholz HM
    Ann Intern Med; 2002 Jul; 137(1):10-6. PubMed ID: 12093240
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Participant demographics reported in "Table 1" of randomised controlled trials: a case of "inverse evidence"?
    Furler J; Magin P; Pirotta M; van Driel M
    Int J Equity Health; 2012 Mar; 11():14. PubMed ID: 22429574
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Using a qualitative sub-study to inform the design and delivery of randomised controlled trials on medicinal cannabis for symptom relief in patients with advanced cancer.
    Olson RE; Smith A; Huggett G; Good P; Dudley M; Hardy J
    Trials; 2022 Sep; 23(1):752. PubMed ID: 36064621
    [TBL] [Abstract][Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.